Publications

Nature medicine

Author Correction: Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults.

International journal of radiation oncology, biology, physics

Toward the End of Planning Target Volume Margins With Online Adaptive Radiation Therapy.

Trends in cancer

Treatment of patients with pMMR GI cancers with tumor-infiltrating lymphocytes (TIL): a reality?

Bioorganic & medicinal chemistry

Design, Synthesis, and Biological Implications of Autotaxin inhibitors with a Three-Point lock binding mode.

JAMA network open

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.

Scientific reports

Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors.

Annals of oncology : official journal of the European Society for Medical Oncology

Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanoma.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with ²²³Ra Therapy in Daily Practice.

British journal of cancer

Rechallenge of ipilimumab and nivolumab in advanced melanoma patients after previous ipilimumab-based therapy.

European journal of cancer (Oxford, England : 1990)

Dose-individualisation of fluoropyrimidines based on pre-treatment serum uracil levels: the Alpe2U study.

European journal of cancer (Oxford, England : 1990)

Neoadjuvant immunotherapy for patients with resectable stage III/IV cutaneous melanoma - A Swedish retrospective real-world study (NEO-MEL).

Cancer immunology, immunotherapy : CII

Dissecting response to neoadjuvant immunotherapy-treated melanoma using cancer-immunity cycle-associated signatures.

Journal for immunotherapy of cancer

SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Differences in travel burden between patients with self-reported curable and incurable cancer: results from a Dutch flash mob study.

23-06-2025

Neuro-oncology

Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small-cell lung cancer better preserves white matter networks compared to conventional PCI.

21-06-2025

Nucleic acids research

Extrusion fountains are restricted by WAPL-dependent cohesin release and CTCF barriers.

20-06-2025

iScience

A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability.

20-06-2025

Nucleic acids research

TRIP12's role in the governance of DNA polymerase β involvement in DNA damage response and repair.

20-06-2025

Journal of patient-reported outcomes

Development of a unified system for assessing health related quality of life across the cancer care continuum: the EUonQoL Delphi study to identify priorities for quality of life domains.

19-06-2025

European journal of cancer (Oxford, England : 1990)

Efficacy of encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the Dutch Melanoma Treatment Registry.

18-06-2025

Journal of cancer survivorship : research and practice

Health-related quality of life of long-term adolescent and young adult (AYA) cancer survivors compared to a matched normative population: results of the SURVAYA study.

17-06-2025

Cancer research

Immunological Tolerance to Luciferase and Fluorescent Proteins Using Tol Mice Enables Development of Improved Tumor Models for Investigating Immunity and Metastasis.

16-06-2025

bioRxiv : the preprint server for biology

Structure of endogenous Pfs230:Pfs48/45 in complex with potent malaria transmission-blocking antibodies.

15-06-2025

Journal of cancer survivorship : research and practice

Prevalence of and factors associated with clinically important levels of fatigue, pain, and insomnia in survivors of cancer: a population-based cross-sectional study.

14-06-2025

Radiation oncology (London, England)

Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020-2023, using registry data and questionnaires.

12-06-2025

Cancer cell

Learning the language of T cell receptors through large-scale screening.

09-06-2025

JCI insight

G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressor.

09-06-2025

Molecular cell

A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.

05-06-2025

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

05-06-2025

Cellular and molecular life sciences : CMLS

CD151 interacts with integrin beta 2 in B cell lymphomas.

04-06-2025

Clinical cancer research : an official journal of the American Association for Cancer Research

Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma.

European journal of cancer (Oxford, England : 1990)

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

European journal of cancer (Oxford, England : 1990)

Durable responses upon short-term addition of targeted therapy to anti-PD1 in advanced melanoma patients: 5-year progression-free and overall survival update of the IMPemBra trial.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Causal Effects of Breast Cancer Risk Factors across Hormone Receptor Breast Cancer Subtypes: A Two-Sample Mendelian Randomization Study.

The Journal of clinical investigation

The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression.

02-06-2025

Radiology

A Data-Centric Approach to Deep Learning for Brain Metastasis Analysis at MRI.

Nature

PLA2G15 is a BMP hydrolase and its targeting ameliorates lysosomal disease.

Clinical genitourinary cancer

Learning From Evidence: Changes in Real-World Use of Second Androgen Receptor Targeted Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC).

British journal of cancer

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis.

British journal of cancer

Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort.

Clinical colorectal cancer

Incidence and Outcomes of Patients With Mismatch Repair Deficient Rectal Cancer Operated in 2016: A Nationwide Cohort From The Netherlands.

The Lancet. Oncology

Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study.

Cancer epidemiology

Notification of locoregional breast cancer recurrence based on pathology reports: A nationwide validation study with the Netherlands Cancer Registry.

ESMO open

Financial toxicity and socioeconomic impact of cancer in Europe.

Key Publication

The Lancet. Oncology

Enfortumab vedotin plus pembrolizumab versus chemotherapy in patients with previously untreated locally advanced or metastatic urothelial cancer (EV-302): patient-reported outcomes from an open-label, randomised, controlled, phase 3 study.

Nature biomedical engineering

Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma.

ESMO real world data and digital oncology

Real-world radiology data for artificial intelligence-driven cancer support systems and biomarker development.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Autologous T-Cell Therapies in Solid Tumor Malignancies: Current Landscape and Future Opportunities.

Contemporary clinical trials communications

Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B).